| N | % | Mean ± SD |
---|---|---|---|
Age at onset of MS, years | Â | Â | Â |
<20 | 59 | 14.5 | Â |
20–28 | 110 | 27.0 |  |
29–38 | 119 | 29.2 |  |
39–49 | 87 | 21.4 |  |
≥50 | 32 | 7.9 |  |
Sex | Â | Â | Â |
Male | 119 | 29.2 | Â |
Female | 288 | 70.8 | Â |
Incomplete recovery from first relapse | Â | Â | Â |
No | 346 | 85.0 | Â |
Yes | 61 | 15.0 | Â |
Initial course of MS | Â | Â | Â |
Remitting-relapsing | 349 | 85.7 | Â |
Primary progressive | 58 | 14.3 | Â |
CSF total protein level, mg/L | Â | Â | Â |
0–500 | 312 | 76.7 |  |
≥500 | 95 | 23.3 |  |
CSF IgG index | Â | Â | Â |
<0.60 | 219 | 53.8 | Â |
≥0.60 | 188 | 46.2 |  |
CSF oligoclonal bands | Â | Â | Â |
No | 53 | 13.0 | Â |
Yes | 354 | 87.0 | Â |
Leukocyte count | Â | Â | Â |
Normal | 151 | 37.1 | Â |
Increased (≥5 mm3) | 256 | 62.9 |  |
Barkhof’s criteria (initial MRI) |  |  |  |
Negative | 48 | 11.8 | Â |
Positive | 359 | 88.2 | Â |
Period of MS onset | Â | Â | Â |
<01/01/98 | 60 | 14.7 | Â |
≥01/01/98 | 347 | 85.3 |  |
Time from MS onset to: (years) | Â | Â | Â |
Lumbar puncture | 407 |  | 4.3 ± 3.2 |
Last follow-up | 407 |  | 8.9 ± 3.8 |